Stock-Based Compensation (Tables)

3 Months Ended

12 Months Ended

Mar. 31, 2013

Dec. 31, 2012

Stock-Based Compensation

Schedule of assumptions on which the expense related to stock options granted is based

The expense related to stock options granted in the three months ended March 31, 2013 was based on the assumptions shown in the table below.

Risk-free interest rate	1.1%
Average life of options (years)	6.0
Volatility	32.63%
Dividend yield	4.3%
Fair value per stock option	$6.87

years ended December 31	2012			2011			2010
Risk-free interest rate		1.2	%		2.7	%		2.9	%
Average life of options (years)		6.0			6.0			6.0
Volatility		21.0	%		21.0	%		22.0	%
Dividend yield		3.6	%		4.1	%		3.2	%
Fair value per stock option	$	6.80		$	6.23		$	9.24

Summary of AbbVie stock option activity for both AbbVie and Abbott employees

(options in thousands, aggregate intrinsic value in millions)	Options		Weighted-average exercise price	Weighted- average remaining life (in years)	Aggregate intrinsic value
Outstanding at December 31, 2012	—		$—
Options converted on January 1, 2013	47,718		27.00
Granted	2,169		36.01
Exercised	(4,017	)	26.42
Lapsed	(31	)	19.87
Outstanding at March 31, 2013	45,839		27.49	4.1	$616
Exercisable at March 31, 2013	42,163		$27.12	3.7	$582

(options in thousands, aggregate intrinsic value in millions)	Options			Weighted average exercise price		Weighted average remaining life (in years)		Aggregate intrinsic value
Outstanding at December 31, 2011		25,783		$	49.77		4.1
Granted		944			62.54
Exercised		(13,347	)		49.62
Lapsed		(95	)		53.88
Outstanding at December 31, 2012		13,285		$	50.80		3.7	$	196
Exercisable at December 31, 2012		12,329		$	50.09		3.6	$	190

Summary of AbbVie RSA and RSU balances for both AbbVie and Abbott employees

(share units in thousands)	Share units		Weighted-average grant date fair value
Outstanding at December 31, 2012	—		$—
Awards converted on January 1, 2013	15,394		27.55
Granted	5,381		35.27
Vested	(7,134	)	27.29
Lapsed	(76	)	29.53
Outstanding at March 31, 2013	13,565		$30.74
Unvested shares at March 31, 2013	13,399		$30.78

(share units in thousands)	Share units			Weighted average grant date fair value
Nonvested shares December 31, 2011		4,710		$	50.29
Granted		2,749			56.07
Vested		(2,164	)		51.23
Lapsed		(251	)		48.62
Nonvested shares December 31, 2012		5,044		$	53.12